According to the SUSTAIN trials, semaglutide has shown significant weight loss in participants
Although these cells play an important role in the defense against extracellular pathogens and in the modulation of epithelial barrier function, they can become pathogenic when exposed, for instance, to a combination of IL-1, IL-6 and IL-23, which activates the pathogenic signature of these cells
It is the stuff that changes the question from 'does it work?' to 'who does it help, for what outcome, and with what tradeoffs?' Regulation does not settle the peptide debate by itself
Bowel obstruction : Some have reported blocked intestines, causing severe abdominal pain, nausea, and vomiting
Acknowledgements We thank all participants who took part in the trial and dedicated their time and effort to attending visits, some traveling very long distances